Skip to content

Prevention and treatment of hypertension in the elderly: The advantages of integrated traditional Chinese and Western medicine

Clinical study of combined treatment of Qinggan Yishen Qufeng Granules and anti-hypertensive drugs on hypertension in the elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018693
Enrollment
Unknown
Registered
2018-10-04
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension in the elderly

Interventions

Group 1:ARB+CCB+diuretic
Group 2:ARB+CCB+diuretic+QGYS Granules

Sponsors

Department of cardiovascular medicine, Minhang Hospital of Integrated Traditional Chinese and Western Medicine (Pending)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 65 to 80 years old; 2. Diagnostic criteria for hypertension: When untreated with antihypertensive drugs and systolic blood pressure=140 mmHg and/or diastolic blood pressure=90mm Hg from three measurements on the same day, a patient can be diagnosed with hypertension is diagnosed. A patient with a history of hypertension and currently takes anti-hypertensive drugs is diagnosed with hypertension whether or not SBP/DBP<140/90mmHg; 3. Patients who have been receiving the oral treatment of triple anti-hypertensive drugs, specifically, ARB, CCB and diuretic; 4. Prior to the trial, dynamic blood pressure examination reveals at least one abnormality of the following: uncontrolled 24-hour average systolic blood pressure/diastolic blood pressure, early morning hypertension, abnormal blood pressure circadian rhythm and abnormal blood pressure variability; 5. The guiding principles of the syndrome differentiation in TCM are met; 6. Signed informed consent forms are obtained.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with secondary hypertension or malignant hypertension; 2. Patients diagnosed with severe cardiovascular diseases, cerebrovascular diseases, severe respiratory diseases, severe liver damages, severe kidney damages or malignant tumors; 3. Patients with infectious diseases such as hepatitis, tuberculosis or AIDS; 4. Patients who are unwilling to join the research.

Design outcomes

Primary

MeasureTime frame
blood pression;

Contacts

Public ContactJinsong Fei

Department of cardiovascular medicine, Minhang Hospital of Integrated Traditional Chinese and Western Medicine (Pending)

doctorfeijinsong@163.com+86 18918168971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026